Patents by Inventor Sharsti SANDALL

Sharsti SANDALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF
    Publication number: 20240123080
    Abstract: Hydrophilic auristatin compounds are described, including Drug-Linker compounds, Ligand-Drug Conjugate compounds, methods of use, and preparations thereof.
    Type: Application
    Filed: August 11, 2023
    Publication date: April 18, 2024
    Inventors: Philip MOQUIST, Svetlana DORONINA, Nicole DUNCAN, Gabriele BLAHNIK-FAGAN, Sharsti SANDALL
  • ANTI-CD228 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
    Publication number: 20240033369
    Abstract: Provided are novel anti-CD228 antibodies and antibody-drug conjugates and methods of using such anti-CD228 antibodies and antibody-drug conjugates to treat cancer.
    Type: Application
    Filed: February 21, 2023
    Publication date: February 1, 2024
    Inventors: Sharsti SANDALL, Lori WESTENDORF, Timothy LEWIS
  • ANTI-CD228 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
    Publication number: 20230295330
    Abstract: Provided are novel anti-CD228 antibodies and antibody-drug conjugates and methods of using such anti-CD228 antibodies and antibody-drug conjugates to treat cancer.
    Type: Application
    Filed: August 3, 2021
    Publication date: September 21, 2023
    Inventors: Sharsti SANDALL, Andrew WAIGHT
  • Anti-CD228 antibodies and antibody-drug conjugates
    Patent number: 11617798
    Abstract: Provided are novel anti-CD228 antibodies and antibody-drug conjugates and methods of using such anti-CD228 antibodies and antibody-drug conjugates to treat cancer.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: April 4, 2023
    Assignee: Seagen Inc.
    Inventors: Sharsti Sandall, Lori Westendorf, Timothy Lewis
  • ANTI-CD228 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
    Publication number: 20200246479
    Abstract: Provided are novel anti-CD228 antibodies and antibody-drug conjugates and methods of using such anti-CD228 antibodies and antibody-drug conjugates to treat cancer.
    Type: Application
    Filed: February 3, 2020
    Publication date: August 6, 2020
    Inventors: Sharsti SANDALL, Lori WESTENDORF, Timothy LEWIS